financetom
Business
financetom
/
Business
/
Dollar General Cuts Full-Year Outlook as Quarterly Results Miss Estimates
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Dollar General Cuts Full-Year Outlook as Quarterly Results Miss Estimates
Sep 1, 2024 4:21 AM

08:55 AM EDT, 08/29/2024 (MT Newswires) -- Dollar General ( DG ) lowered its full-year outlook on Thursday amid softening sales trends, as the discount retailer's fiscal second-quarter results missed Wall Street estimates.

The company now anticipates per-share earnings to come in between $5.50 and $6.20 for fiscal 2024, down from its previous projections of $6.80 to $7.55. Sales are set to rise by roughly 4.7% to 5.3% versus the prior guidance for a 6% to 6.7% increase. The consensus on Capital IQ is for GAAP EPS of $7.12 and revenue of $41.02 billion.

Same-store sales growth is pegged at about 1% to 1.6% for the ongoing fiscal year, compared with the previous forecast for a 2% to 2.7% gain. The Street is looking for same-store sales to incline by 2.5%. The stock tumbled 24% in premarket activity.

The outlook revision reflects softer sales trends and related gross margin impacts, which are expected to continue through the remainder of the fiscal year, according to the retailer. "While we believe the softer sales trends are partially attributable to a core customer who feels financially constrained, we know the importance of controlling what we can control," Chief Executive Todd Vasos said in a statement.

For the three-month period ended Aug. 2, Dollar General's ( DG ) net income dropped 20% year over year to $1.70 a share, missing the Street's view for $1.79. Sales advanced 4.2% to $10.21 billion, but trailed analysts' $10.37 billion estimate.

Same-store sales edged up 0.5% during the quarter, below the 2.1% increase modeled by the market. Higher customer traffic was partially offset by a lower average transaction amount. Same-store sales rose in the consumables category, but home, seasonal and apparel products all recorded declines, according to the company.

"We made important progress on our Back to Basics plan in the second quarter," Vasos said. "However, despite advancing several of our operational goals and driving positive traffic growth, we are not satisfied with our financial results, including top line results below our expectations for the quarter."

Gross profit as a percentage of sales slipped 112 basis points year over year to 30%, mainly due to increased markdowns and inventory damages, among other factors. Selling, general and administrative expenses rose to $2.51 billion from $2.35 billion in the prior-year quarter.

Price: 94.11, Change: -29.73, Percent Change: -24.01

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Olin's $75 Million AMMO Deal Boosts Winchester High-Margin Push
Olin's $75 Million AMMO Deal Boosts Winchester High-Margin Push
Jan 21, 2025
Olin Corporation ( OLN ) and AMMO, Inc. ( POWW ) shares are trading higher on Tuesday after Olin agreed to acquire AMMO’s small caliber ammunition manufacturing assets for $75 million. The transaction, funded through available liquidity, will integrate these assets into Olin’s Winchester Ammunition business. The acquisition includes AMMO’s brass shellcase capabilities and its 185,000-square-foot production facility in Manitowoc,...
Astrana Health Repurchases About $10.6 Million of its Common Shares
Astrana Health Repurchases About $10.6 Million of its Common Shares
Jan 21, 2025
10:52 AM EST, 01/21/2025 (MT Newswires) -- Astrana Health ( ASTH ) said Tuesday it repurchased 300,000 of its common shares on Friday for $35.17 apiece or about a total purchase price of roughly $10.6 million. The company purchased the shares from its shareholder Allied Physicians of California, it added. Astrana Health's ( ASTH ) stock rose 3% in recent...
Market Chatter: International Paper Expected to Get EU Nod for DS Smith Takeover
Market Chatter: International Paper Expected to Get EU Nod for DS Smith Takeover
Jan 21, 2025
10:53 AM EST, 01/21/2025 (MT Newswires) -- International Paper ( IP ) is expected to get the European Commission's approval for its proposed acquisition of DS Smith after agreeing to sell assets to resolve competition concerns, Reuters reported Tuesday, citing people with knowledge of the matter. The regulator previously set a Jan. 24 provisional deadline for a decision on the...
AstraZeneca, Daiichi Sankyo's Datroway Gets US FDA Approval for Advanced Breast Cancer Treatment
AstraZeneca, Daiichi Sankyo's Datroway Gets US FDA Approval for Advanced Breast Cancer Treatment
Jan 21, 2025
10:49 AM EST, 01/21/2025 (MT Newswires) -- AstraZeneca ( AZN ) and Daiichi Sankyo's datopotamab deruxtecan, or datroway, has received approval from the US Food and Drug Administration to treat breast cancer patients who have already undergone endocrine-based therapy and chemotherapy. The approval is based on the results of the Tropion-Breast01 phase 3 trial, which showed a 37% reduction in...
Copyright 2023-2026 - www.financetom.com All Rights Reserved